CROSSTEC (03893) plans to offer a discount of approximately 10.31% for the maximum of 31.104 million shares for sale. The net proceeds are expected to be around 6.01 million Hong Kong dollars.
Yiwei Group (03893) announced that on February 7, 2025, the company entered into a placing agreement with the placing agent...
CROSSTEC (03893) announced that on February 7, 2025, the company entered into a placing agreement with the placing agent. According to this agreement, the placing agent conditionally agreed to use its best efforts to procure not less than 60 individual placees (who are independent third parties) to subscribe for up to a maximum of 31.104 million shares of the company at a placing price of HK $0.20 per share. The placing shares will be issued and allotted under the general mandate.
Assuming that there is no change in the issued share capital of the company from the date of this announcement to the completion date, the maximum number of placing shares under the placing arrangement is 31.104 million shares, representing approximately 16.67% of the enlarged issued share capital of the company after the full issue and allotment of the placing shares as of the date of this announcement. The placing price of HK$0.20 per share represents a discount of approximately 10.31% to the closing price of HK$0.223 per share on the Stock Exchange of Hong Kong on February 7, 2025.
Assuming all placing shares are fully placed, the net proceeds from the placing arrangement (after deducting placing commissions and other expenses) will be approximately HK$6.01 million, equivalent to a net placing price of approximately HK$0.193 per share. The directors propose to use HK$3 million of the net proceeds to pay for subcontracting fees for the interior solution projects, and the remaining HK$3.01 million of the net proceeds will be used for the group's general working capital.
Related Articles

Oral weight loss drug Wegovy performs well, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) stock price rebounds after two years of decline, up about 16% year-to-date.

US Stock Market Move | Tesla, Inc. (TSLA.US) rises over 4%, generously investing $20 billion in AI and the Siasun Robot & Automation track.

US Stock Market Move | KLA Corporation (KLAC.US) tumbles 10% as its performance guidance for the third quarter of the 2026 fiscal year falls below expectations.
Oral weight loss drug Wegovy performs well, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) stock price rebounds after two years of decline, up about 16% year-to-date.

US Stock Market Move | Tesla, Inc. (TSLA.US) rises over 4%, generously investing $20 billion in AI and the Siasun Robot & Automation track.

US Stock Market Move | KLA Corporation (KLAC.US) tumbles 10% as its performance guidance for the third quarter of the 2026 fiscal year falls below expectations.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


